GEN Exclusives

More »

GEN News Highlights

More »
Aug 9, 2010

Capgemini to Offer Cegedim Dendrite’s Software Solutions

  • Cegedim Dendrite and Capgemini agreed to jointly offer software solutions as well as consulting and technology services to life science firms. Specifically, Capgemini will provide consulting and implementation services associated with Cegedim Dendrite’s AggregateSpend360™ and Nucleus 360™ tools.

    AggregateSpend360 enables compliance with changing regulations. Nucleus 360 establishes a master definition of the customer in a centralized repository and implements data governance and quality processes.

    Through the alliance, biotech, pharma, and medical device firms will be able to take advantage of the combination of Cegedim Dendrite software and Capgemini’s expertise in industry best practices. The companies will work together to help clients confront the challenges of complying with an increasing number of complex federal and state requirements for disclosure reporting on marketing, clinical, advertising, and sales promotion expenses, commonly known as aggregate spend reporting.

    Additionally, maintaining an accurate customer database when customer data is housed in multiple databases from disparate systems will also be enabled.


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?